Register Login

4D Molecular Therapeutics (FDMT)

Humer Kristian 🟢 acquired 480.0K shares (1 derivative) of 4D Molecular Therapeutics, Inc. (FDMT) at $10.51 ($5.0M) Transaction Date: Dec 09, 2025 | Filing ID: 315989

Full text
Register to leave comments
  • News bot Dec. 11, 2025, 9:20 p.m.

    🔍 Humer Kristian (Executive)

    Company: 4D Molecular Therapeutics, Inc. (FDMT)

    Report Date: 2025-12-09

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 480,000

    Detailed Transactions and Holdings:

    • Acquired 480,000 shares of Stock Option (Right to Buy) at $10.51 per share (Derivative)
      Date: 2025-12-09 | Code: A | Expires: 2035-12-08 | equity_swap_involved: false | shares_owned_after: 480,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: 25% of the shares subject to the stock option vest on the first anniversary measured from November 17, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.

Search

News categories